Evidence map›Paper›PMID 41988575›Full record

ArticleFrontiers in public health2026

Molecular epidemiological analysis of

Weijie Wang, Xiangyun Liu, Lianzheng Yu, Mingyan Zhang, Tongzhu Wei, Xue Li, Jinghong Ma, Taoran Zhao, Yue Zheng, Qingyuan Wang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Weijie Wang *Liaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Xiangyun Liu *China Medical University, Shenyang, Liaoning, China.
Lianzheng YuLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Mingyan ZhangLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Tongzhu WeiLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Xue LiLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Jinghong MaLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Taoran ZhaoLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Yue ZhengLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Qingyuan WangLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Yan WangLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.
Wenli DiaoLiaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vibrio parahaemolyticus (VP) is a major pathogen causing foodborne diseases, and Liaoning Province, a coastal region with high seafood consumption and production, faces a notable risk of VP-associated foodborne infections. Clarifying the molecular epidemiological characteristics of VP in this region is critical for targeted prevention and control of such diseases. This study aimed to investigate the molecular epidemiological features, virulence gene profiles, and antibiotic resistance gene distribution of VP isolated from foodborne disease cases in Liaoning Province during 2023-2024, providing precise data support for VP prevention and control. Methods: Whole-genome sequencing (WGS) was performed on 261 clinical isolates of Results: A total of 10,413 foodborne disease cases were monitored during 2023-2024, with 261 isolates of Conclusion:

Indexed as

Foodborne DiseasesVibrio InfectionsVibrio parahaemolyticusChinaHumansMolecular EpidemiologyMultilocus Sequence TypingSeafoodVirulenceWhole Genome Sequencingfoodborne illnessMLSTmolecular epidemiologyVibrio parahaemolyticuswhole-genome sequencing

Identifiers

PMID41988575
PMCPMC13076565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.